Skip to main content

Table 2 Outcomes of Patients during Follow-Up

From: Readmissions, revisions, and mortality after treatment for proximal humeral fractures in three large states

 

Initial Treatment

 

Non-Operative

121,411

ORIF

8994

Arthroplasty

4006

p-valueΠ

Revision surgerya:

 ORIF

5410 (4.5%)

225 (2.5%)

73 (1.8%)

0.009

 Arthroplasty

3747 (3.1%)

369 (4.1%)

217 (5.4%)

0.66

All-cause mortality while in-patient

11,876 (9.8%)

787 (8.8%)

401 (10.0%)

0.003

Reasons for readmission

 

Device complications

N/A

475 (5.3%)

270 (6.7%)

< 0.0001

Wound complications

N/A

172 (1.9%)

73 (1.8%)

0.0002

Pulmonary embolism

30 (0.02%)

*

*

0.004

Deep venous thrombosis of lower extremity

1495 (1.2%)

130 (1.4%)

79 (2.0%)

0.33

Venous embolism or thrombosis of other site

127 (0.10%)

15 (0.17%)

*

0.22

Cardiac complications

60 (0.05%)

*

*

0.88

Cardiac rhythm conversion

2405 (2.0%)

150 (1.7%)

89 (2.2%)

0.02

Unspecified septicemia

7131 (5.9%)

491 (5.5%)

265 (6.6%)

0.01

  1. ORIF open reduction and internal fixation
  2. SD standard deviation
  3. * Value < 10
  4. Π p-values of non-operative vs. ORIF vs. arthroplasty as treatment
  5. aPercentages based on initial cohort of subjects